Full Text View
Tabular View
No Study Results Posted
Related Studies
Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients (CHRU01)
This study has been terminated.
( DSMB decision to begin closeout process in view of April 2010 SA HAART guideline )
Study NCT01601899   Information provided by University of Witwatersrand, South Africa

First Received on May 14, 2012.   Last Updated on May 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mitochondrial Toxicity
Metabolic Complications
Interventions listed in this trial
Stavudine
Tenofovir
Additional drug interventions recognized in this trial
Efavirenz
Lamivudine
Tenofovir disoproxil
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antimetabolites
Antiviral Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Reverse Transcriptase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University of Witwatersrand, South Africa


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services